Thursday - January 22, 2026

Tirzepatide Poised for Remarkable Market Expansion of Type 2 Diabetes and Obesity by 2032

Explore DelveInsight’s comprehensive report on Tirzepatide (Eli Lilly) in Las Vegas, USA, featuring market size, forecast, and emerging insights up to 2034.Explore DelveInsight’s comprehensive report on Tirzepatide (Eli Lilly) in Las Vegas, USA, featuring market size, forecast, and emerging insights … Continue reading

Menkes Disease Market Report 2034: 7MM Analysis, USD 7.9 Million Market Size in 2023, 177 Diagnosed Cases, FDA Approvals & Clinical Pipeline | DelveInsight

Menkes Disease Market The report examines Menkes disease across the 7MM, highlighting epidemiology trends, 177 diagnosed prevalent cases, recent FDA approval of Zycubo, current treatment practices, emerging therapies, and key companies shaping the treatment landscape through 2034. The Menkes disease … Continue reading

Acute Myeloid Leukemia Market Forecast to 2034: 7MM Opportunity, Strong CAGR, 43,500 Annual Cases, and Pipeline-Driven Growth | DelveInsight

Acute Myeloid Leukemia Market Robust R&D activity, breakthrough regulatory designations, and precision oncology approaches are driving meaningful change in AML care and commercial dynamics. The Acute Myeloid Leukemia (AML) market is expected to grow at a strong CAGR through 2034 … Continue reading

NM-8074 (Ruxoprubart) Sales Forecast Signals Strong Long-Term Growth Potential Across Complement-Mediated Diseases Through 2034, DelveInsight

NM-8074 (Ruxoprubart) Sales Forecast NM-8074 (ruxoprubart) sales market analysis provides in-depth insights into NM-8074 annual sales, market size, and growth forecast across the 7MM through 2034. The report evaluates NM-8074 sales potential by indication, pricing dynamics, competitive landscape, and regulatory … Continue reading

Liver Cancer Clinical Trials & Drug Pipeline Report: 75+ Therapies, 70+ Companies Analyzed, analyses DelveInsight

Liver Cancer Clinical Trials Liver cancer companies are Arcus Biosciences (NASDAQ: RCUS), Tvardi Therapeutics (NASDAQ: TVRD), GlaxoSmithKline (NYSE: GSK / LSE: GSK), AVEO Pharmaceuticals (formerly NASDAQ: AVEO), Teclison, Epizyme (formerly NASDAQ: EPZM), Sirnaomics (HKEX: 9877), Coherus Biosciences (NASDAQ: CHRS), Sinocelltech … Continue reading

Paltusotine Sales Forecast Signals Significant Market Expansion Driven by Oral Innovation in Acromegaly Care, estimates DelveInsight

Paltusotine Sales Forecast The Paltusotine market is poised for significant expansion following FDA approval as the first once-daily oral therapy for acromegaly. Driven by strong physician adoption, growing patient preference for oral alternatives, and lifecycle expansion opportunities, Paltusotine annual sales … Continue reading